200 related articles for article (PubMed ID: 32361567)
1. IL-27 and autoimmune rheumatologic diseases: The good, the bad, and the ugly.
Shahi A; Afzali S; Salehi S; Aslani S; Mahmoudi M; Jamshidi A; Amirzargar A
Int Immunopharmacol; 2020 Jul; 84():106538. PubMed ID: 32361567
[TBL] [Abstract][Full Text] [Related]
2. IL-27-induced modulation of autoimmunity and its therapeutic potential.
Meka RR; Venkatesha SH; Dudics S; Acharya B; Moudgil KD
Autoimmun Rev; 2015 Dec; 14(12):1131-1141. PubMed ID: 26253381
[TBL] [Abstract][Full Text] [Related]
3. Insights into IL-23 biology: From structure to function.
Floss DM; Schröder J; Franke M; Scheller J
Cytokine Growth Factor Rev; 2015 Oct; 26(5):569-78. PubMed ID: 26195433
[TBL] [Abstract][Full Text] [Related]
4. IL-17D: A Less Studied Cytokine of IL-17 Family.
Liu X; Sun S; Liu D
Int Arch Allergy Immunol; 2020; 181(8):618-623. PubMed ID: 32516792
[TBL] [Abstract][Full Text] [Related]
5. IL-20 receptor cytokines in autoimmune diseases.
Chen J; Caspi RR; Chong WP
J Leukoc Biol; 2018 Nov; 104(5):953-959. PubMed ID: 30260500
[TBL] [Abstract][Full Text] [Related]
6. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
Leng RX; Pan HF; Tao JH; Ye DQ
Expert Opin Ther Targets; 2011 Feb; 15(2):119-26. PubMed ID: 21073280
[TBL] [Abstract][Full Text] [Related]
7. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
[TBL] [Abstract][Full Text] [Related]
8. Inflammasomes and rheumatic diseases: evolving concepts.
Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
[TBL] [Abstract][Full Text] [Related]
9. Current Understanding of IL-37 in Human Health and Disease.
Su Z; Tao X
Front Immunol; 2021; 12():696605. PubMed ID: 34248996
[TBL] [Abstract][Full Text] [Related]
10. The novel interleukin-1 cytokine family members in inflammatory diseases.
Hahn M; Frey S; Hueber AJ
Curr Opin Rheumatol; 2017 Mar; 29(2):208-213. PubMed ID: 27926540
[TBL] [Abstract][Full Text] [Related]
11. Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
Shin JI; Lee KH; Joo YH; Lee JM; Jeon J; Jung HJ; Shin M; Cho S; Kim TH; Park S; Jeon BY; Jeong H; Lee K; Kang K; Oh M; Lee H; Lee S; Kwon Y; Oh GH; Kronbichler A
J Autoimmun; 2019 Sep; 103():102299. PubMed ID: 31326231
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-27 mediates inflammation during chronic disease.
Wynick C; Petes C; Gee K
J Interferon Cytokine Res; 2014 Oct; 34(10):741-9. PubMed ID: 24797503
[TBL] [Abstract][Full Text] [Related]
13. The IL-1 family of cytokines and receptors in rheumatic diseases.
Dinarello CA
Nat Rev Rheumatol; 2019 Oct; 15(10):612-632. PubMed ID: 31515542
[TBL] [Abstract][Full Text] [Related]
14. IL-38: A New Player in Inflammatory Autoimmune Disorders.
Xie L; Huang Z; Li H; Liu X; Zheng S; Su W
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31387327
[TBL] [Abstract][Full Text] [Related]
15. [Influence of genetic polymorphisms (IL-10/CXCL8/CXCR2/NFκB) on the susceptibility of autoimmune rheumatic diseases].
Salim PH; Xavier RM
Rev Bras Reumatol; 2014; 54(4):301-10. PubMed ID: 25627226
[TBL] [Abstract][Full Text] [Related]
16. Potent therapeutic target of inflammation, virus and tumor: focus on interleukin-27.
Duan Y; Jia Y; Wang T; Wang Y; Han X; Liu L
Int Immunopharmacol; 2015 May; 26(1):139-46. PubMed ID: 25812768
[TBL] [Abstract][Full Text] [Related]
17. Targeting IL-23 in autoimmunity.
Hölscher C
Curr Opin Investig Drugs; 2005 May; 6(5):489-95. PubMed ID: 15912962
[TBL] [Abstract][Full Text] [Related]
18. The role of interleukin-4 in rheumatic diseases.
Dong C; Fu T; Ji J; Li Z; Gu Z
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):747-754. PubMed ID: 29655253
[TBL] [Abstract][Full Text] [Related]
19. Role of IL-17 and IL-22 in autoimmunity and cancer.
Blake SJ; Teng MW
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells.
Schaper K; Kietzmann M; Bäumer W
Mol Immunol; 2014 May; 59(1):10-8. PubMed ID: 24434636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
